Investment Q&A

Q: I've done quite nicely on NVO over the last while and have sold off about a third of my original position at prices close to double the current level. With a few US dollars in my account I am wondering if I should buy back some NVO or look at a part position in ISRG (or another healthcare suggestion from 5i) for diversification.

Thanks for all your advice! Though I ask few questions, I learn "bigly" from those of other subscribers.

Q: Recognizing that you don't necessarily follow NVO, do you still consider this a better long term investment compared to PFE with it's attractive dividend? I know that the company's recent trials have not been great, but do they have a better pipeline than PFE?

NVO's revenue and free cash flow seemed to have consistently grown looking in the past, and it appears to be at an historically attractive valuation. But now maybe the most important question going forward is has NVO lost it's "moat" ?

Q: Hi- would welcome your analysis for this growth / defensive name at current price. Is the debt situation still the major concern here? is there remaining headline risk with the trial and consumer pushback?

Q: Now that WELL has achieved control, what upside remains for the minority shareholders?

Q: Hi there, follow up to your answers today on WELL, how much cash is WELL dishing out for AIDX then? How is this being funded by WELL, and therefore affecting WELL's cash/debt position?

Regarding AIDX then, is the current $1.50 share price representing a fair price?

Thanks!

Q: Hi 5i, First thanks for the quick feedback on Wells filing delay. I too thought it had marginal impact. However an analyst from RBC put this out:

“The current situation suggests management may have overlooked certain aspects of the complexity. Until we receive further clarity, we include a 50-per-cent contribution of Circle Medical in our valuation ($68-million, or $0.27/sh) and have also adjusted our valuation to reflect the current market conditions.”

Seems pretty inflammatory, can you help me understand where he gets 50-per-cent contribution?

Thx again

Q: can U explain the deal of Well Health taking over shares of Healwell Aidx/t...I own shares of aidx....is this a buyout/takeover of Healwell???....if so what is the deal/price??....sorry for all the questions but I have read the n/r twice & can't figure it out....thanks, jb

Q: Is this an opportunity to enter a position (on big selloff today) given your positive opinion of the company? What would be your weighing if you owned this stock in a well diversified portfolio?

Q: Peter and His Dream Team
WELL just reported significant services increase for 2024 yet the stock is down 20%. Your assessment please. Are we getting close to the bottom? Thank you as usual.

Q: WELL issued a release about problems with CircleMedical, a subsidiary. They are delayed in filing their financials which has caused WELL to be late. Can you explain the release and what it means/impact to WELL. How serious is this? What do you see the end result being? Would this change your favourable view of WELL?

Q: Does your view of HIMS from 2/25/25 still hold? The recent (negative) volatility you anticipated is proving a bit unnerving?

Q: hi folks, thoughts on Q/FY results for Healwell,(Aidx/t), and with acquistion of Orion expected to close 1 April....thoughts on company going forward....I believe Well Health has a 14% position in Healwell??.....thanks as always, jb

Q: Good morning 5i team,

Recent headline .... "Better Choice Company Shareholders Overwhelmingly Approve Acquisition of SRx Health Solutions and Related Proposals"

Is 5i covering, or planning to cover this Canadian company, SRx?

Thank you.

Edward

Q: Good morning! Can we please have your results comments and expectations going forward on VHI. Thank you.

Q: Twice in the last two weeks you've been asked to provide your list of top 10 stocks with the highest conviction over the next 5-10 years. The lists have been the same, with one exception. The earlier list had ISRG on it; the most recent list replaced ISRG with IFC. Are you losing faith in ISRG?

Q: Can you provide any insight on US healthcare Select SPDR fund,?
Thanks

Q: You had a previous question on earnings coming out March 21 but nothing came out? I also saw something saying it was coming out yesterday. Nothing yet?

Q: Your thoughts on GUD going forward in light of:

07:20 AM EDT, 03/24/2025 (MT Newswires) -- Knight Therapeutics (GUD.TO) overnight Sunday said G252 Capital has disposed of 2.5 million of its shares at $6.30 each, and no longer holds over 10% of Knight's outstanding shares.

G2S2 now owns 7.54 million Knight shares, for a 7.6% stake.

Does this limit upside of the stock price?

Q: I am working on increasing my sector representation in Healthcare. I will shortly have filled a full position in ISRG, adding in this downturn. I have traded around UNH, and am planning to take it from a 1/2 to full position. I have 1/4 position in ILMN and do not think I should be topping it up; I perceive it to be risky. I need 2 more companies, or may need to take one or both of IRSG/UNH to more than a full position.

This provides me a surgical/instrumentation company and a service/product supplier. For diversity in the Healthcare space can you rank your preferred buys (with entry points) I'd appreciate 2 recommendations on the pharmaseuticals side and 2 on the biotech side, or as you may see that fits better.

While I am open US companies I do have a concern that the Trump administration will bring the DOGE and Executive Order train wrecks to health care. I would appreciate your views on this potential action and howe it may impact investment choice in the field.

Thanks as always,

Dave

Q: QSI I have been following this stock for the past few weeks and it has been increasing daily.
Can you provide your usual service in providing a review of this business.
Thanks in advance